About Sanofi Consumer Healthcare India Ltd
Sanofi Consumer Healthcare India is primarily engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/ third party manufacturers based across the country. The Company sells its products in India (through independent distributors) and outside India. The company also provides business support services to its group entity in India.
Founded
2023
CEO
Amit Jain
Employees
597
HQ
Mumbai, Maharashtra
Finished Products
1Sale of Products
₹1,183.20Cr2Sale of Services
₹77.30Cr3Others
₹19.20Cr4Export Incentives
₹0.10Cr5Scrap sales
₹0.10CrRaw Materials
1Cost of Material Consumed
₹136.40Cr2Cost of Materials Consumed
₹127.40Cr3Purchases of Stock-in-Trade
₹42.10Cr4Purchase of Stock-in-Trade
₹20.00CrAbout Sanofi Consumer Healthcare India Ltd
Sanofi Consumer Healthcare India is primarily engaged in the business of manufacturing and trading of drugs and pharmaceutical products. The Company also has various independent contract/ third party manufacturers based across the country. The Company sells its products in India (through independent distributors) and outside India. The company also provides business support services to its group entity in India.
Founded:2023
CEO:Amit Jain
Employees:597
HQ:Mumbai, Maharashtra
Finished Products
1Sale of Products
₹1,183.20Cr2Sale of Services
₹77.30Cr3Others
₹19.20Cr4Export Incentives
₹0.10Cr5Scrap sales
₹0.10CrRaw Materials
1Cost of Material Consumed
₹136.40Cr2Cost of Materials Consumed
₹127.40Cr3Purchases of Stock-in-Trade
₹42.10Cr4Purchase of Stock-in-Trade
₹20.00CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹5,357
52W Low
₹3,975
Volume4.64K
Avg VolumeN/A
Beta0.49
Dividend Yield1.82%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
35.68x
Valuation
P/B Ratio
27.28x
Valuation
EPS
₹115.50
Valuation
Dividend Yield
1.82%
Valuation
ROE
76.46%
Profitability
ROCE
92.74%
Profitability
Revenue by Segment
Contribution & growth by business line
Consumer Healthcare ProductsRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
81.4%
International
18.6%
India81.4%
Outside India18.6%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.06x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
16.5%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.